Deep sclerectomy: results with and without collagen implant
Détails
ID Serval
serval:BIB_899B0EBA8434
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Deep sclerectomy: results with and without collagen implant
Périodique
International Ophthalmology
ISSN
0165-5701 (Print)
Statut éditorial
Publié
Date de publication
1996
Volume
20
Numéro
1-3
Pages
157-62
Notes
Comparative Study
Journal Article
Journal Article
Résumé
PURPOSE: To study the need, the safety and the success rate of collagen implant in eyes that underwent deep sclerectomy, a new non penetrating filtration procedure, we compared the results of deep sclerectomy with (DSCI) and without (DS) collagen implant. METHODS: Of 168 patients (168 eyes) with various types of medically uncontrolled open angle glaucoma, 86 (86 eyes) underwent DSCI, and 82 (82 eyes) underwent DS. Visual acuity, slit lamp examination, intraocular pressure (IOP) measurements were performed before surgery and prospectively at days 1 and 7 and months, 1, 2, 3, 6, 9, 12, 15, 18, and 24 after surgery. Deep sclerectomy was performed according to Kozlov's original technique. The collagen implant drainage device was radially secured in the center of the deep sclerectomy dissection. RESULTS: The mean follow-up period was 9.7 +/- 6.5 months for DSCI, and 9.0 +/- 4.8 months for DS. The mean preoperative IOP was 26.9 +/- 8.8 mmHg for DSCI and 25.8 +/- 8.5 mmHg for DS. The mean postoperative IOP and visual acuity were similar between the two groups. Complete and qualified success rates were better when the collagen implant was used (Log-Rank test: p = 0.0002 and 0.033 for complete and qualified success respectively). The need for postoperative glaucoma medications was significantly lower when the collagen implant was used (0.2 +/- 0.5 versus 0.5 +/- 0.7 medication per patient in the DSCI and DS respectively, Student's t test: p = 0.0038). There was significantly less bleb fibrosis when the collagen implant was used (2% and 11% in DSCI and DS respectively, p = 0.029). CONCLUSION: The collagen implant device is safe, increases the success rate of deep sclerectomy, and lowers the need for postoperative glaucoma medications.
Mots-clé
Aged
Antimetabolites/administration & dosage
*Collagen
Drainage/methods
Female
Fluorouracil/administration & dosage
Follow-Up Studies
Glaucoma/drug therapy/physiopathology/*surgery
Humans
Intraocular Pressure
Male
Postoperative Complications
Postoperative Period
*Prostheses and Implants
Retrospective Studies
Sclerostomy/*methods
Time Factors
Treatment Outcome
Visual Acuity
Pubmed
Création de la notice
28/01/2008 13:49
Dernière modification de la notice
20/08/2019 15:48